Naproxen Sodium description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Naproxen Sodium

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

WARNINGSWARNINGSWARNINGS

NAPROXEN SODIUM DESCRIPTION



Naproxen Sodium






CLINICAL PHARMACOLOGY

Pharmacodynamics


Pharmacokinetics





PRECAUTIONS: Nursing Mothers



WARNINGS: Renal Effects


DOSAGE AND ADMINISTRATION







WARNINGS: Renal Effects

CLINICAL STUDIES

General Information










Geriatric Patients


INDICATIONS & USAGE

WARNINGS














NAPROXEN SODIUM CONTRAINDICATIONS



WARNINGS: Anaphylactoid ReactionsPRECAUTIONS: Preexisting Asthma
WARNINGS

WARNINGS

CARDIOVASCULAR EFFECTS
Cardiovascular Thrombotic Events


Gastrointestinal Effects - Risk of Ulceration, Bleeding, and Perforation
CONTRAINDICATIONS




Gastrointestinal Effects- Risk of Ulceration, Bleeding, and Perforation




Renal Effects
WARNINGS: Advanced Renal Disease
Advanced Renal Disease


Anaphylactoid Reactions
CONTRAINDICATIONSPRECAUTIONS: Preexisting Asthma
Skin Reactions

Pregnancy


PRECAUTIONS

General
Naproxen-containing products such as Naproxen Sodium Tablets, USP, and other naproxen products should not be used concomitantly since they all circulate in the plasma as the naproxen anion.





Hepatic Effects




Hematological Effects


Preexisting Asthma:




INFORMATION FOR PATIENTS

Patients should be informed of the following information before initiating therapy with an NSAID and periodically during the course of ongoing therapy. Patients should also be encouraged to read the NSAID Medication Guide that accompanies each prescription dispensed.
WARNINGS: Cardiovascular Effects
WARNINGS: Gastrointestinal Effects- Risk of Ulceration, Bleeding, and Perforation



WARNINGS



LABORATORY TESTS



DRUG INTERACTIONS











WARNINGS: Renal Effects






Other Information Concerning Drug Interactions




DRUG & OR LABORATORY TEST INTERACTIONS




CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY




PREGNANCY








LABOR & DELIVERY




NURSING MOTHERS



PEDIATRIC USE

DOSAGE AND ADMINISTRATIONDOSAGE AND ADMINISTRATION

GERIATRIC USE


WARNINGS
WARNINGS: Renal Effects

NAPROXEN SODIUM ADVERSE REACTIONS


CLINICAL PHARMACOLOGY


Gastrointestinal (GI) Experiences, including:
Central Nervous System:
Dermatologic:
Special Senses:
Cardiovascular:
General:

Gastrointestinal (GI) Experiences, including:
General:

Body as a Whole:
Cardiovascular:
Gastrointestinal:
Hepatobiliary:
Hemic and Lymphatic:
Metabolic and Nutritional:
Nervous System:
Respiratory:
Dermatologic:
Special Senses:
Urogenital:
Reproduction (female):

Body as a Whole:
Cardiovascular:
Gastrointestinal:
Hepatobiliary:
Hemic and Lymphatic:
Metabolic and Nutritional:
Nervous System:
Respiratory:
Dermatologic:
Special Senses:
Urogenital:


OVERDOSAGE





DOSAGE & ADMINISTRATION

WARNINGS

Different dose strengths and formulations (i.e., tablets, suspension) of the drug are not necessarily bioequivalent. The difference should be taken into consideration when changing formulation.
CLINICAL PHARMACOLOGY
WARNINGSPRECAUTIONS
Geriatric Patients

Patients With Moderate to Severe Renal Impairment
WARNINGS: Renal Effects
Rheumatoid Arthritis, Osteoarthritis and Ankylosing Spondylitis
Naproxen Sodium


CLINICAL PHARMACOLOGY
Juvenile Arthritis

Management of Pain, Primary Dysmenorrhea, and Acute Tendonitis and Bursitis:

Acute Gout:

HOW SUPPLIED

Naproxen Sodium Tablets


Naproxen Sodium Tablets,



STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Naproxen Sodium

Naproxen Sodium

Naproxen Sodium

Naproxen Sodium TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-604(NDC:53746-194)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
naproxen sodium NAPROXEN 550 mg

Inactive Ingredients

Ingredient Name Strength
MAGNESIUM STEARATE
CROSCARMELLOSE SODIUM
POLYVINYL ALCOHOL
povidone
talc
titanium dioxide
FD&C BLUE NO. 2

Product Characteristics

Color Size Imprint Code Shape
blue 12 mm IP;194 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-604-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078432 2011-11-03


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.